107 related articles for article (PubMed ID: 15837383)
21. A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus.
Zimmermann M; Fischbach MA
Chem Biol; 2010 Sep; 17(9):925-30. PubMed ID: 20851341
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo validation of ligA and tarI as essential targets in Staphylococcus aureus.
Streker K; Schäfer T; Freiberg C; Brötz-Oesterhelt H; Hacker J; Labischinski H; Ohlsen K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4470-4. PubMed ID: 18809938
[TBL] [Abstract][Full Text] [Related]
23. Isolation of temperature-sensitive mutations in murC of Staphylococcus aureus.
Ishibashi M; Kurokawa K; Nishida S; Ueno K; Matsuo M; Sekimizu K
FEMS Microbiol Lett; 2007 Sep; 274(2):204-9. PubMed ID: 17608695
[TBL] [Abstract][Full Text] [Related]
24. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule.
Tekbas OF; Ogur R; Korkmaz A; Kilic A; Reiter RJ
J Pineal Res; 2008 Mar; 44(2):222-6. PubMed ID: 18289175
[TBL] [Abstract][Full Text] [Related]
25. Regulation of exoprotein gene expression by the Staphylococcus aureus cvfB gene.
Matsumoto Y; Kaito C; Morishita D; Kurokawa K; Sekimizu K
Infect Immun; 2007 Apr; 75(4):1964-72. PubMed ID: 17283102
[TBL] [Abstract][Full Text] [Related]
26. Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains.
Pichon C; Felden B
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14249-54. PubMed ID: 16183745
[TBL] [Abstract][Full Text] [Related]
27. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
28. Rapid identification of antibacterial agents effective against Staphylococcus aureus using small-molecule macroarrays.
Bowman MD; O'Neill JC; Stringer JR; Blackwell HE
Chem Biol; 2007 Apr; 14(4):351-7. PubMed ID: 17462570
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel essential two-component signal transduction system, YhcSR, in Staphylococcus aureus.
Sun J; Zheng L; Landwehr C; Yang J; Ji Y
J Bacteriol; 2005 Nov; 187(22):7876-80. PubMed ID: 16267314
[TBL] [Abstract][Full Text] [Related]
30. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity of Thymus daenensis methanolic extract.
Mojab F; Poursaeed M; Mehrgan H; Pakdaman S
Pak J Pharm Sci; 2008 Jul; 21(3):210-3. PubMed ID: 18614414
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
Hoban DJ; Bouchillon SK; Johnson BM; Johnson JL; Dowzicky MJ;
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567
[TBL] [Abstract][Full Text] [Related]
33. What is in the pipeline for Gram-negative pathogens?
Talbot GH
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
[TBL] [Abstract][Full Text] [Related]
34. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors.
Blake KL; O'Neill AJ; Mengin-Lecreulx D; Henderson PJ; Bostock JM; Dunsmore CJ; Simmons KJ; Fishwick CW; Leeds JA; Chopra I
Mol Microbiol; 2009 Apr; 72(2):335-43. PubMed ID: 19298367
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital.
Tantracheewathorn T; Vititpatarapak N; Phumisantiphong U
J Med Assoc Thai; 2007 Feb; 90(2):258-65. PubMed ID: 17375629
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
37. Environmental regulation of biofilm development in methicillin-resistant and methicillin-susceptible Staphylococcus aureus clinical isolates.
Fitzpatrick F; Humphreys H; O'Gara JP
J Hosp Infect; 2006 Jan; 62(1):120-2. PubMed ID: 16221507
[No Abstract] [Full Text] [Related]
38. The bacteria fight back.
Taubes G
Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
[No Abstract] [Full Text] [Related]
39. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary relationships between sporadic and epidemic strains of healthcare-associated methicillin-resistant Staphylococcus aureus.
Hallin M; Denis O; Deplano A; De Ryck R; Crèvecoeur S; Rottiers S; de Mendonça R; Struelens MJ
Clin Microbiol Infect; 2008 Jul; 14(7):659-69. PubMed ID: 18558938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
